This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Gamamabs Pharma, Institut Regional Du Cancer De Montpellier, National Institute of Health and Medical Research. Active years: 2021.
Company Filing History:
1 out of 1 
1 out of 16 
1 out of 1,853 
Years Active: 2021
Title: The Innovations of Thierry Chardès
Introduction
Thierry Chardès is a notable inventor based in Assas, France. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work has implications for medical research and therapeutic applications.
Latest Patents
Chardès holds a patent for "Anti-human-HER3 antibodies and uses thereof." This patent describes a neuregulin non-competitive allosteric anti-human-HER3 antibody that features a human constant region. Notably, less than 65% of the glycan structures carried by the glycosylation site of the antibody comprises a fucose molecule. The antibody is characterized by its unique variable sequences, which enhance its functionality.
Career Highlights
Throughout his career, Thierry Chardès has worked with prominent organizations in the biotechnology sector. He has been associated with Gamamabs Pharma, a company focused on developing innovative therapeutic solutions. Additionally, he has contributed to research at the Institut National de la Santé et de la Recherche Médicale, a leading French public research institution.
Collaborations
Chardès has collaborated with esteemed colleagues in his field, including Olivier Dubreuil and André Pelegrin. Their joint efforts have furthered advancements in antibody research and development.
Conclusion
Thierry Chardès is a distinguished inventor whose work in antibody development has the potential to impact medical science significantly. His contributions reflect the importance of innovation in biotechnology and its applications in healthcare.